Literature DB >> 19548314

Generation of mice with a conditional allele for G6pc.

Wen-Tao Peng1, Chi-Jiunn Pan, Eric J Lee, Heiner Westphal, Janice Y Chou.   

Abstract

Glucose-6-phosphatase-alpha (G6Pase-alpha or G6PC) catalyzes the hydrolysis of glucose-6-phosphate to glucose and is a key enzyme in interprandial glucose homeostasis. Mutations in the human G6PC gene, expressed primarily in the liver, kidney, and intestine, cause glycogen storage disease Type Ia (GSD-Ia), an autosomal recessive disorder characterized by a disturbed glucose homeostasis. For better understanding of the roles of G6Pase-alpha in different tissues and in pathological conditions, we have generated mice harboring a conditional null allele for G6pc by flanking Exon 3 of the G6pc gene with loxP sites. We confirmed the null phenotype by using the EIIa-Cre transgenic approach to generate mice lacking Exon 3 of the G6pc gene. The resulting homozygous Cre-recombined null mice manifest a phenotype mimicking G6Pase-alpha-deficient mice and human GSD-Ia patients. This G6pc conditional null allele will be valuable to examine the consequence of tissue-specific G6Pase-alpha deficiency and the mechanisms of long-term complications in GSD-Ia. Published 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19548314      PMCID: PMC2755605          DOI: 10.1002/dvg.20538

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  13 in total

1.  Widespread recombinase expression using FLPeR (flipper) mice.

Authors:  F W Farley; P Soriano; L S Steffen; S M Dymecki
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

2.  Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.

Authors:  S L Mansour; K R Thomas; M R Capecchi
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

3.  Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.

Authors:  H L Greene; A E Slonim; J A O'Neill; I M Burr
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

4.  Cornstarch therapy in type I glycogen-storage disease.

Authors:  Y T Chen; M Cornblath; J B Sidbury
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

Review 5.  Glycogen storage disease type I: indications for liver and/or kidney transplantation.

Authors:  Philippe Labrune
Journal:  Eur J Pediatr       Date:  2002-07-19       Impact factor: 3.183

Review 6.  Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.

Authors:  Janice Yang Chou; Dietrich Matern; Brian C Mansfield; Yuan-Tsong Chen
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

Review 7.  Liver transplantation for glycogen storage disease types I, III, and IV.

Authors:  D Matern; T E Starzl; W Arnaout; J Barnard; J S Bynon; A Dhawan; J Emond; E B Haagsma; G Hug; A Lachaux; G P Smit; Y T Chen
Journal:  Eur J Pediatr       Date:  1999-12       Impact factor: 3.183

8.  Rat small intestine is an insulin-sensitive gluconeogenic organ.

Authors:  M Croset; F Rajas; C Zitoun; J M Hurot; S Montano; G Mithieux
Journal:  Diabetes       Date:  2001-04       Impact factor: 9.461

9.  Intestinal function in glycogen storage disease type I.

Authors:  G Visser; J P Rake; F T M Kokke; P G J Nikkels; P J J Sauer; G P A Smit
Journal:  J Inherit Metab Dis       Date:  2002-08       Impact factor: 4.982

10.  Ontogeny of the murine glucose-6-phosphatase system.

Authors:  C J Pan; K J Lei; H Chen; J M Ward; J Y Chou
Journal:  Arch Biochem Biophys       Date:  1998-10-01       Impact factor: 4.013

View more
  8 in total

1.  Recent development and gene therapy for glycogen storage disease type Ia.

Authors:  Janice Y Chou; Goo-Young Kim; Jun-Ho Cho
Journal:  Liver Res       Date:  2017-09

Review 2.  Studies on glycogen storage disease type 1a animal models: a brief perspective.

Authors:  Irina O Petrova; Svetlana A Smirnikhina
Journal:  Transgenic Res       Date:  2022-08-25       Impact factor: 3.145

Review 3.  Metabolic reprogramming by class I and II histone deacetylases.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Trends Endocrinol Metab       Date:  2012-10-09       Impact factor: 12.015

Review 4.  Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.

Authors:  Janice Y Chou; Hyun Sik Jun; Brian C Mansfield
Journal:  J Inherit Metab Dis       Date:  2014-10-07       Impact factor: 4.982

5.  Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis.

Authors:  Maria M Mihaylova; Debbie S Vasquez; Kim Ravnskjaer; Pierre-Damien Denechaud; Ruth T Yu; Jacqueline G Alvarez; Michael Downes; Ronald M Evans; Marc Montminy; Reuben J Shaw
Journal:  Cell       Date:  2011-05-13       Impact factor: 41.582

6.  Development of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-α deficiency.

Authors:  Roberta Resaz; Cristina Vanni; Daniela Segalerba; Angela R Sementa; Luca Mastracci; Federica Grillo; Daniele Murgia; Maria Carla Bosco; Janice Y Chou; Ottavia Barbieri; Luigi Varesio; Alessandra Eva
Journal:  Dis Model Mech       Date:  2014-09       Impact factor: 5.758

7.  Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia.

Authors:  Jun-Ho Cho; Goo-Young Kim; Chi-Jiunn Pan; Javier Anduaga; Eui-Ju Choi; Brian C Mansfield; Janice Y Chou
Journal:  PLoS Genet       Date:  2017-05-30       Impact factor: 5.917

8.  Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.

Authors:  Joanne A Hoogerland; Fabian Peeks; Brenda S Hijmans; Justina C Wolters; Sander Kooijman; Trijnie Bos; Aycha Bleeker; Theo H van Dijk; Henk Wolters; Albert Gerding; Karen van Eunen; Rick Havinga; Amanda C M Pronk; Patrick C N Rensen; Gilles Mithieux; Fabienne Rajas; Folkert Kuipers; Dirk-Jan Reijngoud; Terry G J Derks; Maaike H Oosterveer
Journal:  J Inherit Metab Dis       Date:  2021-04-07       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.